Belgium· BE-AMP-SAM374071-00
Circlet 0.12 mg/24 h - 0.015 mg/24 h
A vaginalring mit gestagenen und estrogenen product containing ethinylestradiol, registered in Belgium by Organon Belgium. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Vaginalring mit gestagenen und estrogenen is registered in 10 of 19 countries.
Countries holding a registration under ATC G02BB01 (vaginalring mit gestagenen und estrogenen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Vaginalring mit gestagenen und estrogenen · ATC G02BB01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ethinylestradiol
- Manufacturer
- Organon Belgium
- Country
- Belgium (BE)
- ATC code
- G02BB01
- ATC class
- Vaginalring mit Gestagenen und Estrogenen
- Defined daily dose
- 0.0357 DE, V
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- October 3, 2026
Packs & prices · 2
- be_apb2880078
- be_apb7704513
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for vaginalring mit gestagenen und estrogenen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vaginalring mit gestagenen und estrogenen · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Vaginalring mit gestagenen und estrogenen in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEthinylestradiol 10microgram tabletsUCB Pharma Ltd
- FranceETHINYLOESTRADIOL EFFIK 50 microgrammes, compriméEFFIK
- NetherlandsAcelyn 0,05 mg, tablettenACE Pharmaceuticals B.V.
- NorwayEthinyl-Oestradiol effikLaboratories Effik
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- France · Ethinyloestradiol Effik
- Netherlands · Acelyn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1288a048-7117-46a4-bca2-e8f98c4fcd0b GET /v1/drugs/1288a048-7117-46a4-bca2-e8f98c4fcd0b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Vaginal delivery system",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Circlet 0.12 mg/24 h - 0.015 mg/24 h",
"name_fr": "Circlet 0.12 mg/24 h - 0.015 mg/24 h",
"name_nl": "Circlet 0.12 mg/24 h - 0.015 mg/24 h",
"amp_code": "SAM374071-00",
"strengths": [
"2.7000",
"11.7000"
],
"pack_count": 2,
"substances": [
"Ethinylestradiol",
"Etonogestrel"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Vaginal Ring with Progestogen and Estrogen",
"authorisation_numbers": [
"BE374071"
]
}See everything about vaginalring mit gestagenen und estrogenen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.